Additionally, jadomycins are equally potent against estrogen receptor–positive, progesterone receptor–positive, and human epidermal growth factor–overexpressing breast cancer cells (Hall et al, 2015; Bonitto et al, 2021). The gene discussed is PGR; the disease is breast carcinoma.